바이오젠(주)
DE ˙ DB ˙ US09062X1037
€170.90 ↑8.70 (5.36%)
2026-06-04
주가
SecurityDE:IDP / Biogen Inc.
InstitutionMoors & Cabot, Inc.
Latest Disclosed Ownership1,653 shares
Latest Disclosed Value $ 303,044
Moors & Cabot, Inc. reports 10.27% increase in ownership of IDP / Biogen Inc.

On May 8, 2026 - Moors & Cabot, Inc. filed a 13F-HR form disclosing ownership of 1,653 shares of Biogen Inc. (DE:IDP) valued at $256,628 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,499 shares of Biogen Inc.. This represents a change in shares of 10.27% during the quarter. The current value of the position is $282,498 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BIOGEN COM 09062X103 1,653 154 10.27 303 15.21 0.0130
2026-02-10 2025-12-31 13F BIOGEN COM 09062X103 1,499 1,499 264 0.0113
2025-05-08 2025-03-31 13F BIOGEN COM 09062X103 0 -1,335 -100.00 0 -100.00
2025-02-07 2024-12-31 13F BIOGEN COM 09062X103 1,335 215 19.20 204 -5.99 0.0097
2024-11-08 2024-09-30 13F BIOGEN COM 09062X103 1,120 -10 -0.88 217 -16.86 0.0108
2024-08-09 2024-06-30 13F BIOGEN COM 09062X103 1,130 115 11.33 262 19.72 0.0139
2024-05-08 2024-03-31 13F BIOGEN COM 09062X103 1,015 73 7.75 219 -10.29 0.0119
2024-02-14 2023-12-31 13F BIOGEN COM 09062X103 942 131 16.15 244 16.83 0.0152
2023-11-08 2023-09-30 13F BIOGEN COM 09062X103 811 811 208 0.0141
2021-12-08 2021-09-30 13F/A-1 BIOGEN COM 09062X103 0 -635 -100.00 0 -100.00
2021-11-05 2021-09-30 13F BIOGEN COM 09062X103 0 -635 0
2021-08-10 2021-06-30 13F BIOGEN COM 09062X103 635 -95 -13.01 220 7.32 0.0154
2021-05-12 2021-03-31 13F BIOGEN COM 09062X103 730 730 205 0.0157
2021-02-11 2020-12-31 13F BIOGEN COM 09062X103 0 -888 -100.00 0 -100.00
2020-11-09 2020-09-30 13F BIOGEN COM 09062X103 888 85 10.59 252 17.76 0.0237
2020-08-13 2020-06-30 13F BIOGEN COM 09062X103 803 803 214 0.0228
2020-05-12 2020-03-31 13F BIOGEN COM 09062X103 0 -913 -100.00 0 -100.00
2020-01-28 2019-12-31 13F BIOGEN COM 09062X103 913 -270 -22.82 273 -0.73 0.0274
2019-10-22 2019-09-30 13F BIOGEN COM 09062X103 1,183 105 9.74 275 9.13 0.0303
2019-07-18 2019-06-30 13F BIOGEN COM 09062X103 1,078 0 0.00 252 -1.18 0.0319
2019-05-06 2019-03-31 13F/A-1 BIOGEN COM 09062X103 1,078 195 22.08 255 -4.14 0.0347
2019-05-01 2019-03-31 13F BIOGEN COM 09062X103 2,156 1,273 510
2019-02-13 2018-12-31 13F BIOGEN COM 09062X103 883 75 9.28 266 -6.99 0.0418
2018-11-14 2018-09-30 13F BIOGEN COM 09062X103 808 21 2.67 286 24.89 0.0349
2018-08-14 2018-06-30 13F BIOGEN COM 09062X103 787 37 4.93 229 11.71 0.0309
2018-05-18 2018-03-31 13F BIOGEN COM 09062X103 750 10 1.35 205 -13.14 0.0271
2018-02-13 2017-12-31 13F BIOGEN COM 09062X103 740 15 2.07 236 3.51 0.0313
2017-11-16 2017-09-30 13F BIOGEN COM 09062X103 725 725 228 0.0330
2017-05-15 2017-03-31 13F BIOGEN COM 09062X103 0 -825 -100.00 0 -100.00
2017-02-13 2016-12-31 13F BIOGEN COM 09062X103 825 0 0.00 235 -9.27 0.0387
2016-11-14 2016-09-30 13F BIOGEN COM 09062X103 825 -175 -17.50 259 7.02 0.0433
2016-08-08 2016-06-30 13F BIOGEN COM 09062X103 1,000 1,000 0.00 242 0.0425
2016-05-10 2016-03-31 13F BIOGEN COM 09062X103 0 -715 -100.00 0 -100.00
2016-02-09 2015-12-31 13F BIOGEN COM 09062X103 715 0 0.00 218 3.32 0.0399
2015-11-17 2015-09-30 13F BIOGEN COM 09062X103 715 -43 -5.67 211 -31.05 0.0390
2015-08-17 2015-06-30 13F BIOGEN COM 09062X103 758 3 0.40 306 -3.77 0.0498
2015-05-14 2015-03-31 13F BIOGEN COM 09062X103 755 115 17.97 318 46.54 0.0530
2015-02-17 2014-12-31 13F BIOGEN IDEC COM 09062X103 640 -50 -7.25 217 -5.24 0.0368
2014-11-12 2014-09-30 13F BIOGEN IDEC COM 09062X103 690 0 0.00 229 5.53 0.0390
2014-08-11 2014-06-30 13F BIOGEN IDEC COM 09062X103 690 0 0.00 217 2.84 0.0366
2014-05-08 2014-03-31 13F BIOGEN IDEC COM 09062X103 690 690 211 0.0534
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.